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Background:  The  indications  of osteochondral  autograft  implantation  using  the  Mosaicplasty® technique
were  only  recently  extended  to osteochondral  lesions  of  the talus  (OLT),  a site for  which  no medium-
or  long-term  outcome  data  are  available.  Our  objective  here  was  to  evaluate  medium-term  outcomes  in
case-series  of  patients  who  underwent  Mosaicplasty® for OLT  repair.
Hypothesis:  Mosaicplasty® provides  good  medium-term  outcomes  with  low morbidity  when  used  for
OLT repair.
Patients  et  methods:  We  retrospectively  reviewed  cases  of  Mosaicplasty® for OLT  repair,  performed  in
combination  with  malleolar  osteotomy  on the  side  of the  OLT, at either  of  two  centres,  between  1997
and  2013.  Pre-operative  clinical  data  were  collected  from  the  medical  records  and  all  patients  were
re-evaluated.  We  studied  37  patients  with  a  mean  age  of  33 years.
Results:  Mean  follow-up  at  re-evaluation  was  76 months.  Mean  AOFAS  score  at  re-evaluation  was  83
(range,  9–100).  A  work-related  cause  to the  OLT  was  associated  with  signiﬁcantly  poorer  outcomes
(P  =  0.01).  AOFAS  values  were  signiﬁcantly  better  in patients  whose  OLT  size  was  0.5  to  1 cm2.  The  Ogilvie-
Harris  score  at  last  follow-up  was good  or excellent  in  78%  of  patients.  No  patient  experienced  morbidity
related  to the  malleolar  osteotomy.  Persistent  patellar  syndrome  was  noted  in  6 patients.
Discussion:  In  our  case-series,  Mosaicplasty® for OLT  repair  provided  good  medium-term  outcomes  in
78%  of  patients.  Nevertheless,  the  donor-site  morbidity  should  be borne  in  mind.  Mosaicplasty® deserves
to  be viewed  as  a reference  standard  method  for OLT  repair.
Level  of evidence:  IV,  retrospective  study.
©  2014  Elsevier  Masson  SAS.  All  rights  reserved.. Introduction
The treatment of osteochondral lesions of the talus (OLTs) con-
titutes a major surgical challenge, since the cartilage receives no
lood supply and, therefore, has no potential for self-repair. The
atural history of OLTs is the development of ﬁbrous scar tissue
ith impaired mechanical properties compared to cartilage [1,2].
alliative techniques involving defect debridement with or without
n intervention to stimulate the bone marrow provide outcomes
hat are satisfactory in the short term but seem to deteriorate
ver time [3–5]. Mosaicplasty® is a cartilage repair technique that
nvolves implanting osteochondral autografts. Available data indi-
ate similar short-term outcomes compared to those of palliative
echniques.
∗ Corresponding author.
E-mail address: ndelescalopier@gmail.com (N. de l’Escalopier).
http://dx.doi.org/10.1016/j.otsr.2014.11.006
877-0568/© 2014 Elsevier Masson SAS. All rights reserved.The objective of our study was to evaluate medium-term out-
comes of patients who underwent Mosaicplasty® for OLT repair.
Our working hypothesis was that Mosaicplasty® OLT repair was
effective in the medium-term, with durable improvements and low
morbidity rates.
2. Material and methods
2.1. Inclusion and exclusion criteria
We retrospectively included consecutive patients who  under-
went Mosaicplasty® in either of two  centres, between 1997 and
2013. Mosaicplasty® was  performed for one of two  reasons: symp-
tomatic and incapacitating OLT shown by imaging studies to be
greater than 1 cm2 in size and deep, reaching down to the sub-
chondral bone, after failure of optimal conservative treatment for
3 months; or OLT less than 1 cm2 in size after failure of arthro-
scopic surgery (debridement with or without subchondral bone
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Table 1
Pre-operative clinical data.
Sex 29 males, 8 females
Mean age at surgery (min-max) 33 years (17–49 years)
Body mass index, BMI  (Kg/m2)
Mean (min–max) 27 (19–36)
25 < BMI  < 30 40%
BMI > 30 24%
Cause
Traumatic 31 cases (84%)
Non-traumatic 6 cases (16%)
Mean time to surgery (min–max) in months 29 (1–120)
Previous procedures
Arthroscopic debridement 4
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Table 2
Pre-operative radiological ﬁndings.
Type of lesion
“F” 6
“O” 26
“G” 5
Location
Medial side 26, including 14
postero-medial (38%)
Lateral side 11 (30%)
Signs of osteoarthritis (Van Dijk) [7]
Stage 0 (normal) 34
Stage 1 (osteophytes) 3
Stage 2 (decreased joint-space height) 0Removal of the detached fragment 3
Debridement and subchondral perforation 1
timulation by perforation or microfracture). Contra-indications
o Mosaicplasty® were cartilage lesions caused by a tumour, an
nfection, or an inﬂammatory disease; age older than 50 years; and
maging study evidence of osteoarthritis (radiographic joint-space
arrowing and/or mirror lesions by computed tomography [CT]
rthrography or magnetic resonance imaging [MRI]). In patients
ith OLTs less than 1 cm2 in diameter, the ﬁrst-line treatment
as arthroscopic debridement and subchondral perforation or
icrofracture (45 patients).
Fig. 1. Lateral transmalleStage 3 (complete or nearly complete
joint-space obliteration)
0
2.2. Patient groups
Tables 1 and 2 report the clinical and radiological pre-operative
data for the study patients. The OLT was caused by a work-related
injury in 30% of cases.2.3. Operative technique
The same operative technique was  used in all patients, with
either the OATS transfer system (Arthrex Inc., Naples, FL, USA) or
olar approach [6].
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Fig. 2. Medial malleolar osteotomy allowing the implantation of two  grafts.
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Table 4
Functional outcomes.
Score At re-evaluation after
76 months (12–192 months)
AOFAS 83 points (9–100)
Ogilvie-Harris
Excellent 21
Good 8
Fair 5
ing site or number of grafts.
The mean ﬁnal AOFAS score was 83 points (9–100) and the ﬁnal
T
Ohe Acufex Mosaicplasty® system (Smith-Nephew Inc., Andover,
A,  USA). A pneumatic tourniquet was used. Medial malleolar
steotomy was performed in patients with medial OLTs. When
he OLT was located laterally, the surgical approach was  through
he lateral malleolus. The lateral malleolus was  exposed, the ﬁbu-
ar tendons protected, and the anterior and inferior tibio-ﬁbular
igaments were identiﬁed and detached from the tibia with a
ony disc from Chaput’s tubercle; the disc with its ligaments
as reattached using two anchors or a screw at the end of the
rocedure. A supra-ligamentous osteotomy of the lateral malleo-
us was then performed in an oblique plane directed downwards
nd posteriorly [6] (Fig. 1). After debridement and sizing of the
esion using the transplant tool, holes were drilled in the recipi-
nt zone, the diameter of each hole being 1 mm less than that of
he planned graft, along a depth of 20 mm.  The grafts were har-
ested via a para-patellar arthrotomy of the ipsilateral knee, at
he level of the edge of the femoral trochlea, then press-ﬁt into
he drilled holes until they were ﬂush with the healthy cartilage
Fig. 2).
Weight bearing was eliminated for 6 weeks after the procedure.
assive ankle mobilisation was started after 2 weeks.
The procedure was performed via the medial approach in 26
atients and the lateral approach in 11 patients. The donor site
as the medial edge of the trochlea in 15 (40.5%) patients and the
ateral edge in 22 (59.5%) patients. Mean OLT size was  0.85 cm2
range, 0.4–2.12 cm2). Mean number of grafts used was 2.3 (range,
–8) and mean graft diameter was 5.7 mm (range, 2.7–10 mm.  An
dditional procedure was performed in 8 patients: cancellous bone
rafting between the plugs in 1 patient, subchondral bone perfo-
ation in 2 patients, removal of a free intra-articular osteochondral
able 3
gilvie-Harris score [8].
1-Poor 2-Fair 
Pain Pain Pain 
Swelling Moderate/marked Mild, everyday a
Stiffness Limited motion Limited and pain
Limping Marked (walking aid) Moderate 
Activity Limited Moderately decrPoor 3
fragment in 4 patients, and lateral ankle ligament reconstruction in
1 patient.
2.4. Data collection
The pre-operative data were collected from the medical records.
We  recorded gender, age and body mass index (BMI) on the day
of surgery, whether a trauma or work-related injury led to the
OLT, time to surgery, and previous treatments. The initial imag-
ing studies were reviewed by an independent observer at each of
the two  study centres. OLTs were categorised using the FOG (frac-
ture, osteonecrosis, geode) system [2]. Any lesions of osteoarthritis
were evaluated using the radiological classiﬁcation developed by
Van Dijk [7] (Table 3).
The surgical report was examined to collect the intra-operative
data: approach, OLT size, graft number and size, and concomitant
procedures.
At re-evaluation, each patient was assessed by an indepen-
dent examiner at each centre. Any immediate post-operative
complications were recorded. The clinical and functional eval-
uation of the ankle relied on the American Orthopaedic Foot
and Ankle Society (AOFAS) score and the Ogilvie-Harris score
(Fig. 3 and Table 3) [8,9]. Patients were asked about knee com-
plaints. Imaging studies were obtained, including antero-posterior
and lateral radiographs of the ankle and either MRI  or CT-
arthrography.
The statistical analysis was  performed using StatplusTM soft-
ware (AnalystSoft, Alexandria, VA, USA). Data were described as
mean and range. Student’s t test for paired data was  chosen to
look for associations linking outcomes to BMI, age, pattern of OLT,
and graft harvesting method. Values of P ≤ 0.05 were considered
signiﬁcant.
3. Results
Mean follow-up at re-evaluation was  76 months (12–192
months). All included patients were re-evaluated. No immediate
post-operative complications were recorded. Healing of the malle-
olar osteotomy was  achieved consistently. Persistent knee pain was
reported by 6 patients but showed no correlation with the harvest-Ogilvie-Harris score was  good or excellent in 78.4% of patients
(Table 4). In the subgroup followed-up for longer than 4 years,
3-Good 4-Excellent
Mild None
ctivities Après efforts None/minimal
ful Mild None/minimal
Mild None
eased Slightly decreased No limitations
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sFig. 3. A
ean follow-up was 119 months (48–192) and the proportion
f patients with good or excellent outcomes was  81% (17/21).
atients with work-related OLTs had signiﬁcantly lower functional
cores (P = 0.01). In contrast, OLT size between 0.5 and 1 cm2 wascale [9].
associated with signiﬁcantly better functional outcomes (Table 5).
The Ogilvy-Harris score was poor in 3 patients, who  underwent
tibio-talar arthrodesis 3, 7, and 11 years, respectively, after the
Mosaicplasty® procedure.
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Table  5
AOFAS score by body mass index, lesion type, and lesion size.
AOFAS
BMI  (kg/m2)
<  30 83.3 (9–100)
> 30 80.56 (57–100)
Age
<  30 85 (56–100)
30–40 87 (57–100)
>  40 72.5 (9–100)
FOG
F 83 (63–100)
O  83.2 (9–100)
G 79.4 (43–100)
Defect size (cm2)
< 0.5 75.21 (9–100)
0.5–1 90.30 (68–100)a
1–1.5 81.5 (50–100)
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Fig. 4. Computed tomography arthrography 12 months after surgery showing per-
T
O> 1.5 86 (69–100)
a Statistically signiﬁcant difference.
At re-evaluation, radiographs were obtained in all patients, MRI
n 16 patients, and CT-arthrography in 4 patients. In the 20 patients
ith MRI  or CT-arthrography data, the ﬁndings showed integration
f the grafts (Fig. 4). At re-evaluation, 6 (16%) patients exhibited
oint space narrowing, 73 to 132 months after the Mosaicplasty®
rocedure.
. Discussion
Our results showed that Mosaicplasty® OLT repair was effec-
ive in 78.4% of cases after a mean follow-up of more than 6
ears. Major strengths of our study are the inclusion of the largest
ample size to date and the mean follow-up longer than 6 years.
evertheless, the non-comparative retrospective design cannot
emonstrate that Mosaicplasty® is superior over other OLT repair
echniques. It is worth noting that none of our patients was  lost to
ollow-up.
The ﬁrst data on outcomes after Mosaicplasty® OLT repair
ere published in 1997 [10]. Since then, several studies [6,10–19]
btained good outcomes, with a patient satisfaction rate of
0% after 12 to 84 months. However, some of these studies
ere retrospective evaluations of small sample sizes with short
ollow-ups. In our study, medial or lateral malleolar osteotomy
able 6
utcomes of the various techniques identiﬁed by the literature review.
Type of treatment Author, year 
Functional treatment Tol, Foot Ankle Int, 2000 [23] 
Verhagen, Foot Ankle int 2003 [4] 
Palliative techniques Ferkel, Am J Sport Med, 2008 [3] 
Debridement ± microfracture
and/or subchondral perforation
Hunt, Arthroscopy 2003 [24] 
Robinson, JBJS Am,  2003 [25] 
Van  Bergen, JBJS Am, 2013 [26] 
Flick, Foot Ankle, 1985 [27] 
Jarde, Rev Chir Orthop Reparatrice Appar Mot
Mosaicplasty® Our case-series 
Hangody, Foot Ankle Int, 1997 [10] 
Hangody, Foot Ankle Int, 2001 [14] 
Sammarco, Foot Ankle Int, 2002 [18] 
Al  Shaikh, Foot Ankle Int, 2002 [19] 
Baltzer, Arthroscopy 2005 [16] 
Valderrabano et al., Am J Sport Med, 2009 [17
ACI  Whittaker, JBJS, 2005 [29] 
Thermann, Orthopade, 2008 [30] 
Giannini, Am J Sport Med, 2008 [31] 
Anders, International orthopaedics 2012 [32]fect  incorporation of the graft with restoration of a smooth cartilage surface.
provided satisfactory exposure with no medium-term morbidity.
The malleolar osteotomy approach therefore deserves preference,
except in readily accessible lesions of the most anterior part of the
talar dome, which are rare [20].
Outcomes were signiﬁcantly better in the subgroup with OLTs
measuring 0.5 to 1 cm2, in keeping with earlier reports [12,16].
Therefore, Mosaicplasty® is a valid option even for the ﬁrst-
line treatment of lesions less than 1 cm2 in size. Second-line
Mosaicplasty® produces similar outcomes [12]. Neither age nor
BMI  signiﬁcantly inﬂuenced the outcomes, suggesting that the indi-
cations of Mosaicplasty® may  deserve extension to patients older
than 50 years, provided they have no pre-operative evidence of
osteoarthritis. Caution is in order regarding work-related OLTs,
which are associated with poorer outcomes. Time to Mosaicplasty®
was not associated with the outcomes [4]. The main limiting fac-
tor of Mosaicplasty® OLT repair is donor-site morbidity, whose
frequency ranges across studies from 2% to 50%, without any
inﬂuence of graft number or size or of patient age or weight
[11,13,16,17,21,22].
Functional methods [23] and other techniques (Table 6) have
been reported as treatments for OLTs. “Palliative” methods produce
No. of cases Mean FU Excellent or
good outcome
OA
201 – 45% –
– – 45% –
50 71 months 72% 34%
37 66 months 46% –
65 3.5 years 52% –
50 12 years 78% 33%
22 24 months 79% 33%
 2000 [28] 30 47 months 75% 23%
37 76 months 78% 16%
11 16 months 100% –
36 4.2 years 94% –
12 25 months 100% 50%
19 16 months 89% –
23 12 months 73% –
] 20 72 months 92% 100%
10 4 years 90% –
9 4 years 100% –
46 36 months 80% –
 22 63.5 months 95% –
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drogenesis in osteochondral lesions of the talus. Foot Ankle Clin 2013;18:02 N. de l’Escalopier et al. / Orthopaedics & Trau
ood short-term outcomes (in about 80% of patients, comparable
o those of Mosaicplasty® [27,33,34] with a simpler post-operative
ourse and no donor-site morbidity [2,4,28,35]. However, the
esults deteriorate over time, with nearly 50% of patients hav-
ng poor outcomes after more than 4 years [24,25] and 33%
xhibiting signs of osteoarthritis after 5 to 12 years [3,26]. These
esults are consistent with the inability of palliative treatment
o restore the cartilage. Palliative treatment should not be used
s the ﬁrst-line method unless the defect is small (< 1 cm2)
36]. Our results demonstrate that second-line Mosaicplasty® after
ailed palliative treatment is effective. Thus, Mosaicplasty® is the
nly method that restores the mechanical properties of the talus
37]. Few data on allografting have been reported [38]. Allograft-
ng avoids donor-site morbidity but carried a potential risk of
athogenic virus transmission [38,39]. Autologous chondrocyte
rafts [29–32], platelet-rich plasma, and composite grafts [40–42]
eem promising but need to be evaluated in larger numbers of
atients.
. Conclusion
Mosaicplasty® is a reliable technique and the only means of
btaining durable improvements in patients with OLTs. At present,
osaicplasty® can be viewed as the reference standard ﬁrst-line
reatment for OLTs measuring more than 1 cm2 and as the second-
ine treatment for smaller OLTs. The non-negligible donor-site
orbidity deserves note, however, and the development of com-
osite grafts might constitute a solution.
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